A new macropterous Nocticola Bolivar, 1892 (Blattodea: Nocticolidae) from Singapore

Lucañas Cristian C.,Maosheng Foo 한국응용곤충학회 2023 Journal of Asia-Pacific Entomology Vol.26 No.2

A new epigean Nocticola Bolivar, N. pheromosa n. sp., is described from Singapore. This serves as the first record of the genus in Singapore. The new species closely resembles N. adebratti Roth in Roth & McGavin, 1994 in terms of macroptery and the shape of the ocelli but differs in terms of wing venations and male genital structure. Nocticola adebratti Roth from Borneo is redescribed. A key to known macropterous Nocticola is provided. urn:lsid:zoobank.org:pub:66E068F2-4F41-4BF4-9C16-7D8C2E824E15.

Dietary analysis of eight insectivorous bats (Chiroptera) from Puting Bato Cave Complex, Burdeos, Polillo Island, Philippines

Phillip A. Alviola,Marnelli S. Alviola,Kirk J. Taray,Cristian C. Lucañas,Anna Pauline O. de Guia,Aimee Lynn B. Dupo,Virginia C. Cuevas,Nelson M. Pampolina,Ireneo L. Lit Jr. 국립중앙과학관 2023 Journal of Asia-Pacific Biodiversity Vol.16 No.3

Food habits of eight insectivorous bat species from Puting Bato Cave Complex, Polillo Island, wereexamined. Fecal samples collected from eight species of cave-dwelling insectivorous bats containedculled fragments from seven prey taxa (six insect orders and one fish prey). Lepidoptera, Coleoptera, andHymenoptera were the most consumed group in both percentage volume and percentage frequency. Thediet of Hipposideros diadema, H. pygmaeus, Rhinolophus arcuatus, and R. philippinensis mostly concurswith previous studies but with varying proportions. Baseline information on the diets of H. coronatus,M. paululus, R. macrotis, and R. rufus is provided in this study.

Single nucleotide polymorphism of GSTP1 and pathological complete response in locally advanced rectal cancer patients treated with neoadjuvant concomitant radiochemotherapy

Luca Nicosia,Giovanna Gentile,Chiara Reverberi,Giuseppe Minniti,Maurizio Valeriani,Vitaliana de Sanctis,Luca Marinelli,Fabiola Cipolla,Ottavia de Luca,Maurizio Simmaco,Mattia F. Osti 대한방사선종양학회 2018 Radiation Oncology Journal Vol.36 No.3

Purpose: Standard treatment for locally advanced rectal cancer consists of neoadjuvant radiochemotherapy with concomitant fluoropyrimidine or oxaliplatin and surgery with curative intent. Pathological complete response has shown to be predictive for better outcome and survival; nevertheless there are no biological or genetic factors predictive for response to treatment. We explored the correlation between the single nucleotide polymorphisms (SNPs) GSTP1 (A313G) and XRCC1 (G28152A), and the pathological complete response and survival after neoadjuvant radiochemotherapy in locally advanced rectal cancer patients. Materials and Methods: Genotypes GSTP1 (A313G) and XRCC1 (G28152A) were determined by pyrosequencing technology in 80 patients affected by locally advanced rectal cancer. Results: The overall rate of pathological complete response in our study population was 18.75%. Patients homozygous AA for GSTP1 (A313G) presented a rate of pathological complete response of 26.6% as compared to 8.5% of the AG+GG population (p = 0.04). The heterozygous comparison (AA vs. AG) showed a significant difference in the rate of pathological complete response (26.6% vs. 6.8%; p = 0.034). GSTP1 AA+AG patients presented a 5- and 8-year cancer-specific survival longer than GSTP1 GG patients (87.7% and 83.3% vs. 44.4% and 44.4%, respectively) (p = 0.014). Overall survival showed only a trend toward significance in favor of the haplotypes GSTP1 AA+AG. No significant correlations were found for XRCC1 (G28152A). Conclusion: Our results suggest that GSTP1 (A313G) may predict a higher rate of pathological complete response after neoadjuvant radiochemotherapy and a better outcome, and should be considered in a more extensive analysis with the aim of personalization of radiation treatment.

Single nucleotide polymorphism of GSTP1 and pathological complete response in locally advanced rectal cancer patients treated with neoadjuvant concomitant radiochemotherapy

Nicosia, Luca,Gentile, Giovanna,Reverberi, Chiara,Minniti, Giuseppe,Valeriani, Maurizio,de Sanctis, Vitaliana,Marinelli, Luca,Cipolla, Fabiola,de Luca, Ottavia,Simmaco, Maurizio,Osti, Mattia F. The Korean Society for Radiation Oncology 2018 Radiation Oncology Journal Vol.36 No.3

Purpose: Standard treatment for locally advanced rectal cancer consists of neoadjuvant radiochemotherapy with concomitant fluoropyrimidine or oxaliplatin and surgery with curative intent. Pathological complete response has shown to be predictive for better outcome and survival; nevertheless there are no biological or genetic factors predictive for response to treatment. We explored the correlation between the single nucleotide polymorphisms (SNPs) GSTP1 (A313G) and XRCC1 (G28152A), and the pathological complete response and survival after neoadjuvant radiochemotherapy in locally advanced rectal cancer patients. Materials and Methods: Genotypes GSTP1 (A313G) and XRCC1 (G28152A) were determined by pyrosequencing technology in 80 patients affected by locally advanced rectal cancer. Results: The overall rate of pathological complete response in our study population was 18.75%. Patients homozygous AA for GSTP1 (A313G) presented a rate of pathological complete response of 26.6% as compared to 8.5% of the AG+GG population (p = 0.04). The heterozygous comparison (AA vs. AG) showed a significant difference in the rate of pathological complete response (26.6% vs. 6.8%; p = 0.034). GSTP1 AA+AG patients presented a 5- and 8-year cancer-specific survival longer than GSTP1 GG patients (87.7% and 83.3% vs. 44.4% and 44.4%, respectively) (p = 0.014). Overall survival showed only a trend toward significance in favor of the haplotypes GSTP1 AA+AG. No significant correlations were found for XRCC1 (G28152A). Conclusion: Our results suggest that GSTP1 (A313G) may predict a higher rate of pathological complete response after neoadjuvant radiochemotherapy and a better outcome, and should be considered in a more extensive analysis with the aim of personalization of radiation treatment.

The Underutilization of Lifestyle Modifications in Primary Care Medicine

Jean-Marc Lucas(Jean-Marc Lucas ),Karl F. Kozlowski(Karl F. Kozlowski ) 사피엔시아 2019 Exercise Medicine Vol.3 No.-

Chronic disease accounts for the majority of deaths in the United States and is often attributed to obesity. A sedentary lifestyle and poor nutrition are primary contributing factors to the development of obesity and thus chronic disease. Primary care providers are optimally positioned to prescribe exercise and nutrition (lifestyle medicine) as a treatment for chronic disease. Unfortunately, this opportunity seems to be regularly lost. Primary care providers often rely too heavily on weight loss pharmaceuticals and bariatric surgeries to treat obesity. This treatment approach however also does little to prevent and treat the accumulation of chronic diseases. The purpose of this review was to evaluate the efficacy of conventional medical weight loss treatments and determine why primary care providers may not prescribe exercise and nutrition more frequently. Our findings suggest that some primary care providers may be uncomfortable prescribing lifestyle medicine as they receive little formal education in this field. In conclusion, prescription of exercise and nutrition by primary care providers may elicit greater long-term weight loss than current medical weight management practices. Medical management is most likely effective when combined with lifestyle medicine. We propose that primary care providers be better trained in lifestyle medicine through their formal and clinical education. Rates of chronic disease accumulation may potentially decrease if providers prescribe lifestyle medical treatments more frequently.

99mTc-Pertechnetate Scintigraphy Predicts Successful Postoperative Ablation in Differentiated Thyroid Carcinoma Patients Treated with Low Radioiodine Activities

Luca Giovanella,Gaetano Paone,Teresa Ruberto,Luca Ceriani,Pierpaolo Trimboli 대한내분비학회 2019 Endocrinology and metabolism Vol.34 No.1

Background: Postoperative routine radioiodine (RAI) treatment is currently debated for patients with low-risk differentiated thyroidcarcinoma (DTC) patients. If performed, a low 131I activity (i.e., 1 to 2 GBq) is recommended with the aim to ablate thyroid remnantand facilitate subsequent follow-up by thyroglobulin measurement. The purpose of this study was to evaluate the relationship between postsurgical technetium-99m (99mTc)-pertechnetate scintigraphy and the rate of successful remnant ablation after low activityradioiodine ablation in patients with DTC. Methods: Enrolled were 193 patients with low risk DTC who underwent total thyroidectomy and RAI ablation with a fixed 1.1 GBqactivity of 131I. 99mTc-pertechnetate scans were done and thyrotropin stimulated thyroglobulin (sTg) levels measured just before ablation. Ablation effectiveness was assessed 6 to 12 months later by sTg measurement, neck ultrasound and diagnostic whole body scan. Results: A negative 99mTc-perthecnetate scans was the best predictor of successful ablation (P<0.001) followed by preablative sTglevels <0.8 ng/mL (P=0.008) and 99mTc-pertechnetate uptake rate values <0.9% (P=0.065). Neither sex nor age of the patient at thetime of ablation or tumor histology and size showed a significant association with the rate of successful ablation. Conclusion: The 99mTc-pertechnetate scintigraphy is a simple and feasible tool to predict effectiveness of low activity 131I thyroid toablate thyroid remnants in patients with DTC.

DLC Coatings for Hydraulic Applications

Luca Nobili,Luca Magagnin 한국표면공학회 2008 한국표면공학회 학술발표회 초록집 Vol.2008 No.-

Dental students’ ability to detect maxillary sinus abnormalities: A comparison between panoramic radiography and cone-beam computed tomography

Lucas de Paula Lopes Rosado,Izabele Sales Barbosa,Sibele Nascimento de Aquino,Rafael Binato Junqueira,Francielle Silvestre Verner 대한영상치의학회 2019 Imaging Science in Dentistry Vol.49 No.3

Purpose: To compare the diagnostic ability of undergraduate dental students to detect maxillary sinus abnormalities in panoramic radiographs (PR) and cone-beam computed tomography (CBCT). Materials and Methods: This was a retrospective study based on the evaluation of PR and CBCT images. A pilot study was conducted to determine the number of students eligible to participate in the study. The images were evaluated by 2 students, and 280 maxillary sinuses were assessed using the following categories: normal, mucosal thickening, sinus polyp, antral pseudocyst, nonspecific opacification, periostitis, antrolith, and antrolith associated with mucosal thickening. The reference standard was established by the consensus of 2 oral radiologists based on the CBCT images. The kappa test, receiver operating characteristic curves, and 1-way analysis of variance with the Tukey-Kramer post-hoc test were employed. Results: Intraobserver and interobserver reliability showed agreement ranging from substantial (0.809) to almost perfect (0.922). The agreement between the students’ evaluations and the reference standard was reasonable (0.258) for PR and substantial (0.692) for CBCT. Comparisons of values of sensitivity, specificity, and accuracy showed that CBCT was significantly better (P<0.05). Conclusion: CBCT was better than PR for the detection of maxillary sinus abnormalities by dental students. However, CBCT should only be requested after a careful analysis of PR by students and more experienced professionals.

Distal migration of a partially covered duodenal stent requiring emergency surgical extraction

Luca Giovanni Campana,Rebecca Fish,Owen Thomas Dickinson,Mairéad Geraldine McNamara,Sarah Theresa O’Dwyer,Hans-Ulrich Laasch 소화기인터벤션의학회 2022 Gastrointestinal Intervention Vol.11 No.2

Duodenal stenting is an established alternative for the palliation of malignant gastric outlet obstruction (MGOO). Despite being relatively rare, stent migration remains an issue of concern. We present a case of duodenal stent displacement in a 71-year-old female with biliary and duodenal strictures secondary to pancreatic cancer. She presented with acute abdominal pain 10 days following the insertion of a 24-mm partially covered double-layer knitted device, which migrated to the ileocaecal junction. Since the priority was to minimise hospitalisation, we performed a laparotomy with extraction through an enterotomy combined with gastrojejunostomy to bypass the duodenum. The patient resumed oral intake on postoperative day 9 and tolerated a semi-solid diet for 3 months, until death. Despite continuous advances in enteral stent design, patient surveillance remains paramount. This report illustrates the complex decision-making around MGOO, addresses the management of stent migration, and highlights the role of surgery in simultaneously treating stent complications and palliating duodenal obstruction.

Sequential Use of 90Y Microspheres Radioembolization and 177Lu-Dotatate in Pluri-Metastatic Neuroendocrine Tumors: A Case Report

Luca Filippi,Alida Ciorra,Barbara Sardella,Orazio Schillaci,Oreste Bagni 대한핵의학회 2014 핵의학 분자영상 Vol.48 No.4

Abstract 90Y radioembolization and peptide-receptor radionuclidetherapy (PRRT) with177Lu-DOTATATE are both effectivetreatments for patients with inoperable neuroendocrinemetastatic tumors (NET). We report the case of a 72-year-oldman with severe functional syndrome due to a metastaticNET. 68Ga-DOTATOC positron-emission tomography (PET)revealed high somatostatin receptor expression in a gross livermetastasis, in one abdominal lymph node and in severals k e l e t a l l esions. The patient underwent l iverradioembolization with 90Y-resin microspheres followed byfour cycles of PRRT with177Lu-DOTATATE. After 3 months,a complete remission of the functional syndrome was observed. 68Ga-DOTATOC PET demonstrated a complete responsefor skeletal and lymph nodal lesions with a residualbulky mass in the liver. Therefore a further 90Yradioembolization was performed as consolidation treatmentfor the hepatic lesion. Six months after these combined treatments,68Ga-DOTATOC PET demonstrated complete metabolicresponse in liver and stable extrahepatic lesions. Nosignificant long-term adverse reactions were registered. Toour knowledge, the sequential use of 90Y radiembolizationbefore and after PRRT in a liver-dominant advanced NET hasnot been reported in the literature and this case suggests thatthese combined treatments can be safe and effective.